Lois A. Daamen

1.8k total citations
47 papers, 348 citations indexed

About

Lois A. Daamen is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Lois A. Daamen has authored 47 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Oncology, 22 papers in Surgery and 16 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lois A. Daamen's work include Pancreatic and Hepatic Oncology Research (34 papers), Cancer Genomics and Diagnostics (13 papers) and Pancreatitis Pathology and Treatment (12 papers). Lois A. Daamen is often cited by papers focused on Pancreatic and Hepatic Oncology Research (34 papers), Cancer Genomics and Diagnostics (13 papers) and Pancreatitis Pathology and Treatment (12 papers). Lois A. Daamen collaborates with scholars based in Netherlands, United States and Germany. Lois A. Daamen's co-authors include Hjalmar C. van Santvoort, Vincent P. Groot, Martijn Intven, Marc G. Besselink, I. Quintus Molenaar, I. Quintus Molenaar, Inne H. Borel Rinkes, H.D. Heerkens, Olivier R. Busch and I. Quintus Molenaar and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Annals of Surgery and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Lois A. Daamen

36 papers receiving 343 citations

Peers

Countries citing papers authored by Lois A. Daamen

Since Specialization

Citations

This map shows the geographic impact of Lois A. Daamen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lois A. Daamen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lois A. Daamen more than expected).

Fields of papers citing papers by Lois A. Daamen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lois A. Daamen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lois A. Daamen. The network helps show where Lois A. Daamen may publish in the future.

Co-authorship network of co-authors of Lois A. Daamen

This figure shows the co-authorship network connecting the top 25 collaborators of Lois A. Daamen. A scholar is included among the top collaborators of Lois A. Daamen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lois A. Daamen. Lois A. Daamen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Longitudinal health-related quality of life in patients with pancreatic cancer stratified by treatment: a nationwide cohort study 2025 ·EClinicalMedicine ·(unknown), Pauline A. J. Vissers, Mirjam A. G. Sprangers, (unknown), (unknown), Lydia G. van der Geest, Geert A. Cirkel, Judith de Vos‐Geelen, Marjolein Y.V. Homs, G.J. Creemers, Martijn W.J. Stommel, Lois A. Daamen, Marc G. Besselink, Johanna W. Wilmink, Hanneke W.M. van Laarhoven	0
2	Quality of Life and Toxicity in Patients With Pancreatic Ductal Adenocarcinoma Treated With Online Adaptive Stereotactic Magnetic Resonance Guided Radiation Therapy 2025 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), (unknown), (unknown), Uffe Bernchou, (unknown), (unknown), John P. Christodouleas, (unknown), Cihan Gani, (unknown), Filippo Alongi, Paul Renz, Athanasios Colonias, Gert J. Meijer, Tine Schytte, (unknown), (unknown), Lois A. Daamen, (unknown)	0
3	The Efficacy of Targeted Monoclonal IgA Antibodies Against Pancreatic Ductal Adenocarcinoma 2025 ·Cells ·(unknown), (unknown), (unknown), Mitchell Evers, (unknown), (unknown), (unknown), I. Quintus Molenaar, Hjalmar C. van Santvoort, Karin Strijbis, Martijn Intven, Lois A. Daamen, Jeanette H.W. Leusen, (unknown)	0
4	Defining the Minimal and Optimal Thresholds for Lymph Node Resection and Examination for Intraductal Papillary Mucinous Neoplasm–derived Pancreatic Cancer 2024 ·Annals of Surgery ·Joseph R. Habib, (unknown), (unknown), (unknown), (unknown), Shuang Zhang, D. Brock Hewitt, Steven M. Cohen, Hjalmar C. van Santvoort, Marc G. Besselink, I. Quintus Molenaar, Jin He, Christopher L. Wolfgang, Ammar A. Javed, Lois A. Daamen	9
5	Quality of life and clinical outcomes in rectal cancer patients treated on a 1.5T MR-Linac within the MOMENTUM study 2024 ·Clinical and Translational Radiation Oncology ·Lois A. Daamen, (unknown), Alice M. Couwenberg, Pètra M. Braam, Heidi Rütten, (unknown), John P. Christodouleas, William A. Hall, (unknown), Martijn Intven	2
6	Patient-Reported Outcomes Following Magnetic Resonance-Guided Radiation Therapy for Prostate Cancer: A Systematic Review and Meta-Analysis 2024 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), (unknown), (unknown), Lauren E. Henke, (unknown), A. Bruynzeel, Filippo Alongi, William A. Hall, Amar U. Kishan, Martijn Intven, Helena M. Verkooijen, Jochem R.N. van der Voort van Zyp, Lois A. Daamen	2
7	Treatment time and learning curve analysis of 1.5 T MR-Linac workflows led by radiation oncologists or therapists 2024 ·Clinical and Translational Radiation Oncology ·(unknown), (unknown), Lois A. Daamen, Eline N. de Groot-van Breugel, (unknown), (unknown), (unknown), Stella Mook, (unknown), Martijn Intven	1
8	An international multi-institutional validation of T1 sub-staging of intraductal papillary mucinous neoplasm-derived pancreatic cancer 2024 ·JNCI Journal of the National Cancer Institute ·Joseph R. Habib, (unknown), (unknown), (unknown), Benedict Kinny‐Köster, (unknown), D. Brock Hewitt, Greg D. Sacks, Ammar A. Javed, Marc G. Besselink, Hjalmar C. van Santvoort, Lois A. Daamen, Martin Loos, Jing He, I. Quintus Molenaar, Markus W. Büchler, Christopher L. Wolfgang	3
9	Late cholangitis after pancreatoduodenectomy: A common complication with or without anatomical biliary obstruction 2024 ·Surgery ·(unknown), (unknown), (unknown), Lois A. Daamen, (unknown), Wouter J.M. Derksen, Lydi M.J.W. van Driel, Casper H.J. van Eijck, Krijn P. van Lienden, I. Quintus Molenaar, Hjalmar C. van Santvoort, Frank P. Vleggaar, Bas Groot Koerkamp, Robert C. Verdonk	4
10	Outcomes in intraductal papillary mucinous neoplasm‐derived pancreatic cancer differ from PanIN‐derived pancreatic cancer 2024 ·Journal of Gastroenterology and Hepatology ·Joseph R. Habib, (unknown), Ammar A. Javed, (unknown), Benedict Kinny‐Köster, (unknown), D. Brock Hewitt, Greg D. Sacks, Marc G. Besselink, Hjalmar C. van Santvoort, Lois A. Daamen, Martin Loos, Jing He, Markus W. Büchler, Christopher L. Wolfgang, I. Quintus Molenaar	7
11	The Effect of Radiation Treatment of Solid Tumors on Neutrophil Infiltration and Function: A Systematic Review 2024 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), (unknown), Gert J. Meijer, I. Quintus Molenaar, Hjalmar C. van Santvoort, Martijn Intven, Jeanette H.W. Leusen, (unknown), Lois A. Daamen	8
12	Clinical outcomes after online adaptive MR-guided stereotactic body radiotherapy for pancreatic tumors on a 1.5 T MR-linac 2023 ·Frontiers in Oncology ·(unknown), (unknown), Lois A. Daamen, H.D. Heerkens, Saskia van de Ven, Stella Mook, Gert J. Meijer, I. Quintus Molenaar, Hjalmar C. van Santvoort, E.S. Paulson, (unknown), Helena M. Verkooijen, William A. Hall, Martijn Intven	8
13	The Use of MR-Guided Radiation Therapy for Pancreatic Cancer 2023 ·Seminars in Radiation Oncology ·Lois A. Daamen, Parag J. Parikh, William A. Hall	7
14	Nationwide evaluation of pancreatic cancer networks ten years after the centralization of pancreatic surgery 2023 ·HPB ·(unknown), Lois A. Daamen, Gijs A. Patijn, Judith de Vos‐Geelen, Sebastiaan Festen, Bert A. Bonsing, Marcel Verheij, John J. Hermans, Marco J. Bruno, Roeland F. de Wilde, Ignace H. J. T. de Hingh, Marc G. Besselink, Kees J.H.M. van Laarhoven, Martijn W.J. Stommel	0
15	Outcomes of Tolerability, Acute Toxicity and Quality of Life from MR-Guided Radiation Therapy (1.5T MR-Linac) for Liver Metastases in the MOMENTUM Study 2023 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), (unknown), K. Aitken, (unknown), Pètra M. Braam, Lois A. Daamen, Ali Hosni, Martijn Intven, Tomas Janssen, Tine Schytte, Jan‐Jakob Sonke, (unknown), (unknown), William A. Hall, Marlies E. Nowee	1
16	Pancreatic exocrine insufficiency following pancreatoduodenectomy: A prospective bi-center study 2022 ·Pancreatology ·(unknown), Lois A. Daamen, Dorine S.J. Tseng, (unknown), (unknown), Olivier R. Busch, (unknown), Arja Gerritsen, Steffi Rombouts, F. Jasmijn Smits, Marieke S. Walma, (unknown), Marc G. Besselink, Hjalmar C. van Santvoort, I. Quintus Molenaar	11
17	Clinical benefit of surveillance after resection of pancreatic ductal adenocarcinoma: A systematic review and meta-analysis 2021 ·European Journal of Surgical Oncology ·James Halle‐Smith, (unknown), Lois A. Daamen, James Hodson, Rupaly Pandé, Alastair L. Young, Nigel B. Jamieson, Ángela Lamarca, Hjalmar C. van Santvoort, I. Quintus Molenaar, Juan W. Valle, Keith Roberts	13
18	Magnetic Resonance Guided Radiation Therapy for Pancreatic Adenocarcinoma, Advantages, Challenges, Current Approaches, and Future Directions 2021 ·Frontiers in Oncology ·William A. Hall, Christina Small, E.S. Paulson, Eugene J. Koay, Christopher H. Crane, Martijn Intven, Lois A. Daamen, Gert J. Meijer, H.D. Heerkens, M. Bassetti, Stephen A. Rosenberg, K. Aitken, Sten Myrehaug, Laura A. Dawson, Percy Lee, Cihan Gani, Michael D. Chuong, Parag J. Parikh, Bradley A. Erickson	29
19	Postoperative surveillance of pancreatic cancer patients 2019 ·European Journal of Surgical Oncology ·Lois A. Daamen, Vincent P. Groot, Martijn Intven, Marc G. Besselink, Olivier R. Busch, Bas Groot Koerkamp, Nadia Haj Mohammad, John J. Hermans, Hanneke W.M. van Laarhoven, Joost J. Nuyttens, Johanna W. Wilmink, Hjalmar C. van Santvoort, I. Quintus Molenaar, Martijn W.J. Stommel	38
20	Systematic review on the role of serum tumor markers in the detection of recurrent pancreatic cancer 2018 ·HPB ·Lois A. Daamen, Vincent P. Groot, H.D. Heerkens, Martijn Intven, Hjalmar C. van Santvoort, I. Quintus Molenaar	41

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact